Questions about COVID-19?

What Patients & Families Need to Know | Visitor PolicyGuidance for Community Healthcare Providers

A photo of Adam Nelson.

Member, Division of Bone Marrow Transplantation and Immune Deficiency

Assistant Professor, UC Department of Pediatrics

513-803-3218

513-803-1969

About Me

Academic Affiliation

Assistant Professor, UC Department of Pediatrics

Divisions

Bone Marrow Transplantation BMT, Cancer and Blood Diseases, Langerhans Cell Histiocytosis, Fanconi Anemia, Immune Deficiencies and Histiocytosis

My Locations

My Education

BMedSci: University of Sydney, Australia, 2002.

MBBS(Hons): University of Sydney, Australia, 2006.

Residency: Sydney Children's Hospital, Australia, 2011.

Fellowship: Sydney Children's Hospital, Australia, 2014.

BMT Fellowship: Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2015.

My Publications

Complement blockade for TA-TMA: lessons learned from a large pediatric cohort treated with eculizumab. Jodele, S; Dandoy, CE; Lane, A; Laskin, BL; Laskin, B; Teusink-Cross, A; Myers, KC; Wallace, G; Nelson, AS; Nelson, A; et al. Blood. 2020; 26:S138-S138.

EBV-directed viral-specific T-lymphocyte therapy for the treatment of EBV-driven lymphoma in two patients with primary immunodeficiency and DNA repair defects. Rubinstein, JD; Burns, K; Absalon, M; Lutzko, C; Leemhuis, T; Chandra, S; Hanley, PJ; Keller, MD; Davies, SM; Nelson, A; et al. Pediatric Blood and Cancer. 2020; 67.

High-risk LCH in infants is serially transplantable in a xenograft model but responds durably to targeted therapy. Lee, LH; Krupski, C; Clark, J; Wunderlich, M; Lorsbach, RB; Grimley, MS; Burwinkel, M; Nelson, A; Kumar, AR. Blood Advances. 2020; 4:717-727.

CD38brightCD8+ T Cells Associated with the Development of Acute GVHD Are Activated, Proliferating, and Cytotoxic Trafficking Cells. Khandelwal, P; Chaturvedi, V; Owsley, E; Lane, A; Heyenbruch, D; Lutzko, CM; Leemhuis, T; Grimley, MS; Nelson, AS; Davies, SM; et al. Biology of Blood and Marrow Transplantation. 2020; 26:1-6.

Pediatric and Young Adult Vulvovaginal Graft-versus-Host Disease. Cizek, SM; El-Bietar, J; Rubinstein, J; Dandoy, C; Wallace, GH; Nelson, A; Khandelwal, P; Myers, KC; Hoefgen, HR. Biology of Blood and Marrow Transplantation. 2019; 25:2408-2415.

Outcomes after bloodstream infection in hospitalized pediatric hematology/oncology and stem cell transplant patients. Dandoy, CE; Kelley, T; Gaur, AH; Nagarajan, R; Demmel, K; Alonso, PB; Guinipero, T; Savelli, S; Hakim, H; Owings, A; et al. Pediatric Blood and Cancer. 2019; 66.

Reduction in Nephrotoxic Antimicrobial Exposure Decreases Associated Acute Kidney Injury in Pediatric Hematopoietic Stem Cell Transplant Patients. Benoit, SW; Goldstein, SL; Dahale, DS; Haslam, DB; Nelson, A; Truono, K; Davies, SM. Biology of Blood and Marrow Transplantation. 2019; 25:1654-1658.

Xenon-129 MRI detects ventilation deficits in paediatric stem cell transplant patients unable to perform spirometry. Walkup, LL; Myers, K; El-Bietar, J; Nelson, A; Willmering, MM; Grimley, M; Davies, SM; Towe, C; Woods, JC. The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology. 2019; 53:1801779-1801779.

Understanding the evolving phenotype of vascular complications in telomere biology disorders. Higgs, C; Crow, YJ; Adams, DM; Chang, E; Jr, HD; Herbig, U; Huang, JN; Himes, R; Jajoo, K; Johnson, FB; et al. Angiogenesis. 2019; 22:95-102.

The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases. Thakar, MS; Broglie, L; Logan, B; Artz, A; Bunin, N; Burroughs, LM; Fretham, C; Jacobsohn, DA; Loren, AW; Kurtzberg, J; et al. Blood. 2019; 133:754-762.